ASZ1 and infection: Both p429 and p429‐ORF3 vaccines elicited a specific antibody response, resulting in significantly lower virus excretion in faeces and delayed onset of viral shedding compared to the non‐vaccinated infection control group (p < 0.01 for both vaccines, Figure 2).